InvestSMART

The article you are trying to access does not exist, however, here are some articles you may be interested in.

Invion Limited (ASX: IVX) - Announcements

Current share price for IVX : $0.038 0.002 (5%)+

ASX company news and announcements for Invion Limited (IVX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Invion Limited (IVX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Invion Limited (IVX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Invion Limited (IVX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$4 Application for quotation of securities - IVX 28 Jun 2024 6:25PM $0.004 $0.038 risen by 850%
$4 Proposed issue of securities - IVX 28 Jun 2024 8:22AM $0.005 $0.038 risen by 660%
$4 Invion secures funding through an institutional placement 28 Jun 2024 8:21AM $0.005 $0.038 risen by 660%
$4 Change in substantial holding 7 Jun 2024 1:31PM $0.005 $0.038 risen by 744.44%
$4 Agreement with Major South Korean Pharma Group Hanlim 8 May 2024 9:16AM $0.005 $0.038 risen by 660%
$4 Activities Report and Appendix 4C 30 Apr 2024 1:12PM $0.005 $0.038 risen by 660%
$4 Presentation at East-West Summit in Singapore 5 Mar 2024 8:37AM $0.005 $0.038 risen by 660%
$4 INV043 With ICI Therapy Achieved 80% Tumour Control For ASCC 4 Mar 2024 4:06PM $0.005 $0.038 risen by 660%
$4 Appendix 4D and Half Year Financial Report 28 Feb 2024 9:29AM $0.006 $0.038 risen by 533.33%
$4 Agreement with Dr.inB to develop Photosoft treatment for HPV 23 Feb 2024 9:04AM $0.004 $0.038 risen by 850%
$4 Activities Report and Appendix 4C 30 Jan 2024 8:55AM $0.004 $0.038 risen by 850%
$4 Change of Director's Interest Notice- Robert Merriel 19 Jan 2024 9:22AM $0.005 $0.038 risen by 744.44%
$4 Section 708A Cleansing Statement 19 Jan 2024 9:20AM $0.005 $0.038 risen by 744.44%
$4 Application for quotation of securities - IVX 19 Jan 2024 9:17AM $0.005 $0.038 risen by 744.44%
$4 Change of Auditor 16 Jan 2024 9:55AM $0.005 $0.038 risen by 660%
$4 Notification regarding unquoted securities - IVX 29 Nov 2023 4:54PM $0.007 $0.038 risen by 442.86%
$4 Results of Annual General Meeting 29 Nov 2023 3:01PM $0.006 $0.038 risen by 533.33%
$4 AGM Presentation 29 Nov 2023 9:14AM $0.007 $0.038 risen by 442.86%
$4 Major Milestone towards Clinical Trials 21 Nov 2023 2:13PM $0.006 $0.038 risen by 533.33%
$4 Notification of cessation of securities - IVX 30 Oct 2023 9:12AM $0.007 $0.038 risen by 442.86%
$4 Notice of Annual General Meeting/Proxy Form 30 Oct 2023 8:59AM $0.007 $0.038 risen by 442.86%
$4 Investor Presentation 24 Oct 2023 9:35AM $0.005 $0.038 risen by 660%
$4 Activities Report and Appendix 4C 24 Oct 2023 8:17AM $0.005 $0.038 risen by 660%
$4 Appendix 4G and Corporate Governance Statement 28 Sep 2023 3:50PM $0.005 $0.038 risen by 660%
$4 Annual Report to shareholders 28 Sep 2023 1:21PM $0.005 $0.038 risen by 660%

176 - 200 of 712 results

Page 8 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.